In Lake Zone, Tanzania, low contraceptive prevalence, closely spaced births, and child stunting are common. Synergies exist between postpartum family planning (PPFP) and maternal, infant, and young child nutrition (MIYCN), yet health services are often provided in silos. This qualitative formative research study aimed to identify barriers and facilitating factors for optimal nutrition and PPFP practices in Mara and Kagera, Tanzania. Results informed the program design of an integrated nutrition and family planning (FP) implementation approach. The study involved in-depth interviews with mothers of infants under 1 year (n = 24), grandmothers (n = 12), health providers (n = 6), and traditional birth attendants (n = 12), and 14 focus group discussions with community health workers, fathers, and community leaders. Findings reveal that breastfeeding initiation was often delayed, and prelacteal feeding was common. Respondents linked insufficient breast milk to inadequate maternal nutrition-in terms of the quality of the diet and small quantities of food consumed by mothers. Breast milk insufficiency was addressed through early introduction of foods and liquids. Mothers believed that breastfeeding prevents pregnancy, regardless of the frequency or duration of breastfeeding, yet were generally not aware of the lactational amenorrhea method (LAM) of FP. Joint decision-making on FP was viewed as important, and women often discussed it with their partner. Future programming should address misconceptions about return to fecundity knowledge gaps and concerns about FP methods including LAM; and perceptions regarding insufficient breast milk and early introduction of foods which are impediments to optimal MIYCN and FP practices.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593746 | PMC |
http://dx.doi.org/10.1111/mcn.12735 | DOI Listing |
Value Health
December 2024
Australian Genomics, Melbourne, Australia; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Objectives: The multifaceted ways in which genomics can be valuable to clinicians, patients, families, and society are important for informing prioritisation decisions by policy makers. This study aims to develop a standardised, cumulative and preference-weighted Genomic Utility Valuation (GUV) on a scale 0-100%.
Methods: A multicriteria decision analysis (MCDA) was conducted with experts involved in policy, clinical, research, and consumer advocacy leadership in Australia for the valuation of policy priority indicators of genomic utility.
J Am Board Fam Med
December 2024
From the Family and Community Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL (IA); Family Medicine, Oregon Health & Science University, Portland, OR (SE); Family Medicine, University of Washington, Seattle, WA (AW); and Association of Departments of Family Medicine, Leawood, KS (SE, AW).
Qual Life Res
December 2024
Akdeniz University Hospital, Antalya, 07070, Türkiye.
Background: Despite advances in transplant procedures, children and adolescents still face some challenges post-transplant and are at high risk for psychiatric, academic, and social problems. This study aims to explore the lived experiences of adolescent kidney transplant recipients through interviews and the use of mandala art therapy.
Methods: This study adopted a descriptive phenomenological design and thematic analysis approach based on Husserl's philosophy.
Adv Healthc Mater
December 2024
School of Medicine, 411 Hospital of Shanghai University, Shanghai University, Shanghai, 200444, China.
Hepatic diseases cause serious public health problems worldwide, and there is an urgent need to develop effective therapeutic agents. In recent years, significant progress is made in RNA therapy, and RNA molecules, such as mRNAs, siRNAs, miRNAs, and RNA aptamers, are shown to provide significant advantages in the treatment of hepatic diseases. However, the drawbacks of RNAs, such as their poor biological stability, easy degradation by nucleases in vivo, low bioavailability, and low concentrations in target tissues, significantly limit the clinical application of RNA-based drugs.
View Article and Find Full Text PDFCureus
November 2024
Department of Community Medicine, Al-Rayan National College of Medicine, Madinah, SAU.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!